Li LY - Search Results

1

[Efficacy and safety of erlotinib as monotherapy for advanced non-small cell lung cancer].

Wang MZ, Zhang XT, Zhang XY, Zhang L, Zhong W, Xu LY, Li LY. Wang MZ, et al. Among authors: li ly. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Apr;32(2):151-6. doi: 10.3881/j.issn.1000-503X.2010.02.005. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20450543 Clinical Trial. Chinese.

2

[Efficacy and safety of arbidol in treatment of naturally acquired influenza].

Wang MZ, Cai BQ, Li LY, Lin JT, Su N, Yu HX, Gao H, Zhao JZ, Liu L. Wang MZ, et al. Among authors: li ly. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):289-93. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004. PMID: 15266832 Clinical Trial. Chinese.

3

[Gefitinib for advanced bronchioloalveolar carcinoma].

Zhang XT, Wang SL, Li LY. Zhang XT, et al. Among authors: li ly. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):340-3. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004. PMID: 15266843 Chinese.

4

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Mu XL, Li LY, Zhang XT, Wang SL, Wang MZ. Mu XL, et al. Among authors: li ly. BMC Cancer. 2004 Aug 19;4:51. doi: 10.1186/1471-2407-4-51. BMC Cancer. 2004. PMID: 15318946 Free PMC article. Clinical Trial.

5

[Treatment of non-small cell lung cancer with gefitinib].

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ. Zhang XT, et al. Among authors: li ly. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Mar;28(3):180-3. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 15854414 Chinese.

6

Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L. Wang MZ, et al. Among authors: li ly. Chin Med J (Engl). 2006 Jan 5;119(1):63-8. Chin Med J (Engl). 2006. PMID: 16454984 No abstract available.

7

[Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer].

Zhang L, Wang SL, Zhang XT, Li LY, Wang MZ. Zhang L, et al. Among authors: li ly. Zhonghua Nei Ke Za Zhi. 2007 May;46(5):392-5. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637309 Chinese.

8

[Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].

Wu C, Li LY, Wang MZ, Zhang L, Zhang XT, Zhong W, Wang SL, Wang HZ. Wu C, et al. Among authors: li ly. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):943-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478938 Clinical Trial. Chinese.

9

[Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer].

Wang MZ, Zhong W, Zhang L, Li LY, Wang SL, Li JR, Zhang XT. Wang MZ, et al. Among authors: li ly, li jr. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):221-4. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756941 Clinical Trial. Chinese.

10

[Evaluation of efficacy and safety of ZD1839 as monotherapy in Chinese patients with advanced non-small cell lung cancer].

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L, Li JR. Wang MZ, et al. Among authors: li ly, li jr. Zhonghua Nei Ke Za Zhi. 2008 Apr;47(4):291-5. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18843952 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,360 results

Search Page

Filters